Eligibility and efficacy of a CPC- and CHX-based antiviral mouthwash for the elimination of SARS-CoV-2 from the saliva: A randomized, double-blind, controlled clinical trial.
Brunello GiuliaWolf ViktoriaKerberger RobertBernhard MichaelLübke NadineBecker JürgenSchwarz-Herzke BerylTimm JörgKathrin BeckerPublished in: Journal of clinical periodontology (2023)
Within the limitation of this study, there was no evidence that the intervention reduced salivary SARS-CoV-2 viral load during the course of 60 min. Therefore, commonly used pre-procedural rinsing might not be clinically relevant.